Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis
AUTOR(ES)
Gent, Jürgen
FONTE
The National Academy of Sciences
RESUMO
The regulatory effect of growth hormone (GH) on its target cells is mediated via the GH receptor (GHR). GH binding to the GHR results in the formation of a GH-(GHR)2 complex and the initiation of signal transduction cascades via the activation of the tyrosine kinase JAK2. Subsequent endocytosis and transport to the lysosome of the ligand-receptor complex is regulated via the ubiquitin system and requires the presence of an intact ubiquitin-dependent endocytosis (UbE) motif in the cytosolic tail of the GHR. Recently, the model of ligand-induced receptor dimerization has been challenged. In this study, ligand-independent GHR dimerization is demonstrated in the endoplasmic reticulum and at the cell surface by coimmunoprecipitation of an epitope-tagged truncated GHR with wild-type GHR. In addition, evidence is provided that the extracellular domain of the GHR is not required to maintain this interaction. Internalization of a chimeric receptor, which fails to dimerize, is independent of an intact UbE-motif. Therefore, we postulate that dimerization of GHR molecules is required for ubiquitin system-dependent endocytosis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=125043Documentos Relacionados
- The ubiquitin conjugation system is required for ligand-induced endocytosis and degradation of the growth hormone receptor.
- Immune system-dependent and -independent replication of the scrapie agent.
- Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone.
- Epidermal growth factor receptor cytoplasmic domain mutations trigger ligand-independent transformation.
- Ligand-independent dimerization of oncogenic v-erbB products involves covalent interactions.